Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
The use of zebrafish larvae in basic and applied research has grown exponentially during the last 20 years. The reasons for this success lay in its specific experimental advantages: on the one hand, the small size, the large number of progeny and the fast life cycle greatly facilitate large-scale ap...
Main Authors: | Carles Cornet, Vincenzo Di Donato, Javier Terriente |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00703/full |
Similar Items
-
Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
by: Yan Feng, et al.
Published: (2016-08-01) -
ZeOncoTest: Refining and Automating the Zebrafish Xenograft Model for Drug Discovery in Cancer
by: Carles Cornet, et al.
Published: (2019-12-01) -
Comparison of Various Nuclear Localization Signal-Fused Cas9 Proteins and Cas9 mRNA for Genome Editing in Zebrafish
by: Peinan Hu, et al.
Published: (2018-03-01) -
CRISPR/Cas9 in zebrafish: An attractive model for FBN1 genetic defects in humans
by: Xiaoyun Yin, et al.
Published: (2021-10-01) -
Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM
by: Yunxing Liu, et al.
Published: (2021-08-01)